Joanna Korfanty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanna Korfanty has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Wiesława Widłak
Maria Skłodowska‐Curie National Research Institute of Oncology, Gliwice Branch Gliwice Poland
4 shared publications - Agnieszka Toma-Jonik
Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland
3 shared publications - Natalia Vydra
Maria Skłodowska‐Curie National Research Institute of Oncology, Gliwice Branch Gliwice Poland
3 shared publications - Agnieszka Gogler-Pigłowska
Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Institute-Oncology Center Gliwice Branch, Wybrzeże Armii Krajowej 15, 44-101, Gliwice, Poland
2 shared publications - Piotr Widlak
2nd Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland
2 shared publications - Agnieszka Czarniecka
3rd Department of Oncological Surgery M. Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
1 shared publication
Latest Publications
- 11 February 2016
- Published by Bioscientifica in Endocrine Abstracts
Mouse model of BRAFV600E-induced papillary thyroid carcinoma - summary of our results
Introduction: BRAFV600E mutation is the most frequent alteration in papillary thyroid carcinoma (PTC). Although its relation to factors of poor prognosis was demonstrated in many studies the use of BRAF as a predictive marker in clinical treatment of PTC patients is controversial. The aim of our study was to analyze molecular consequences of BRAFV600E mutation in a transgenic mouse model performed for this purpose and to refer the obtained results to human PTCs. Material and methods: Gene expression profiling was performed for the selected mouse samples obtained from the transgenic mouse model of BRAFV600E-induced PTC with the affymetrix platform and the data were referred to human thyroid dataset with particular emphasis on early steps of PTC carcinogenesis. Results and conclusions: Most BRAF(+) mice developed malignant lesions (83%), of which 15% presented metastases to lungs or extrathyroidal invasion to muscles. These results confirm the initiating potential of the V600E mutation and its association with the aggressive PTC phenotype. Nevertheless 16% of BRAF(+) mice displayed non-malignant benign hyperplastic lesions or healthy thyroids. Gene signature obtained from the comparison of mouse non-malignant BRAF(+) to BRAF(−) thyroids enabled selection of 862 significantly deregulated genes, of which 532 were identified on the human HG-U133A microarray. We believe that the list of 532 genes represents the human signature of an early stage of BRAFV600E-derived PTC. On comparison of BRAF(+) PTCs to RET(+), RAS(+), or PTCs without BRAF and RET alterations and to healthy thyroids, 18 of the 532 genes displayed significantly deregulated expression in all comparisons. Seven out of 18 genes have not been previously reported to be related to BRAF mutation or thyroid carcinoma. Obtained results may be useful in development of new therapeutic strategies that would be able to overcome resistance to BRAF-targeted therapies. Polish NSC grant no N N401 612440.
- 11 February 2016
- Published by Bioscientifica in Endocrine Abstracts
Mouse model of BRAFV600E-induced papillary thyroid carcinoma - summary of our results
Introduction: BRAFV600E mutation is the most frequent alteration in papillary thyroid carcinoma (PTC). Although its relation to factors of poor prognosis was demonstrated in many studies the use of BRAF as a predictive marker in clinical treatment of PTC patients is controversial. The aim of our study was to analyze molecular consequences of BRAFV600E mutation in a transgenic mouse model performed for this purpose and to refer the obtained results to human PTCs. Material and methods: Gene expression profiling was performed for the selected mouse samples obtained from the transgenic mouse model of BRAFV600E-induced PTC with the affymetrix platform and the data were referred to human thyroid dataset with particular emphasis on early steps of PTC carcinogenesis. Results and conclusions: Most BRAF(+) mice developed malignant lesions (83%), of which 15% presented metastases to lungs or extrathyroidal invasion to muscles. These results confirm the initiating potential of the V600E mutation and its association with the aggressive PTC phenotype. Nevertheless 16% of BRAF(+) mice displayed non-malignant benign hyperplastic lesions or healthy thyroids. Gene signature obtained from the comparison of mouse non-malignant BRAF(+) to BRAF(−) thyroids enabled selection of 862 significantly deregulated genes, of which 532 were identified on the human HG-U133A microarray. We believe that the list of 532 genes represents the human signature of an early stage of BRAFV600E-derived PTC. On comparison of BRAF(+) PTCs to RET(+), RAS(+), or PTCs without BRAF and RET alterations and to healthy thyroids, 18 of the 532 genes displayed significantly deregulated expression in all comparisons. Seven out of 18 genes have not been previously reported to be related to BRAF mutation or thyroid carcinoma. Obtained results may be useful in development of new therapeutic strategies that would be able to overcome resistance to BRAF-targeted therapies. Polish NSC grant no N N401 612440.
- Open Access
- 1 February 2015
- Published by Elsevier in Cellular Signalling
- Vol. 27 (2) , 394-401
Active heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation
- 1 February 2015
- Published by Elsevier in Cellular Signalling
- Vol. 27 (2) , 394-401
Open AccessActive heat shock transcription factor 1 supports migration of the melanoma cells via vinculin down-regulation
- Open Access
- 1 December 2014
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 57, 76-83
Crosstalk between HSF1 and HSF2 during the heat shock response in mouse testes
- 1 December 2014
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 57, 76-83
Open AccessCrosstalk between HSF1 and HSF2 during the heat shock response in mouse testes
- Open Access
- 8 July 2013
- Published by Springer Nature in BMC Genomics
- Vol. 14 (1) , 1-22
Impact of heat shock transcription factor 1 on global gene expression profiles in cells which induce either cytoprotective or pro-apoptotic response following hyperthermia
Background: Elevated temperatures induce activation of the heat shock transcription factor 1 (HSF1) which in somatic cells leads to heat shock proteins synthesis and cytoprotection. However, in the male germ cells (spermatocytes) caspase-3 dependent apoptosis is induced upon HSF1 activation and spermatogenic cells are actively eliminated.Results: To elucidate a mechanism of such diverse HSF1 activity we carried out genome-wide transcriptional analysis in control and heat-shocked cells, either spermatocytes or hepatocytes. Additionally, to identify direct molecular targets of active HSF1 we used chromatin immunoprecipitation assay (ChIP) combined with promoter microarrays (ChIP on chip). Genes that are differently regulated after HSF1 binding during hyperthermia in both types of cells have been identified. Despite HSF1 binding to promoter sequences in both types of cells, strong up-regulation ofHspsand other genes typically activated by the heat shock was observed only in hepatocytes. In spermatocytes HSF1 binding correlates with transcriptional repression on a large scale. HSF1-bound and negatively regulated genes encode mainly for proteins required for cell division, involved in RNA processing and piRNA biogenesis.Conclusions: Observed suppression of the transcription could lead to genomic instability caused by meiotic recombination disturbances, which in turn might induce apoptosis of spermatogenic cells. We propose that HSF1-dependent induction of cell death is caused by the simultaneous repression of many genes required for spermatogenesis, which guarantees the elimination of cells damaged during heat shock. Such activity of HSF1 prevents transmission of damaged genetic material to the next generation.
- 8 July 2013
- Published by Springer Nature in BMC Genomics
- Vol. 14 (1) , 1-22
Open AccessImpact of heat shock transcription factor 1 on global gene expression profiles in cells which induce either cytoprotective or pro-apoptotic response following hyperthermia
Background: Elevated temperatures induce activation of the heat shock transcription factor 1 (HSF1) which in somatic cells leads to heat shock proteins synthesis and cytoprotection. However, in the male germ cells (spermatocytes) caspase-3 dependent apoptosis is induced upon HSF1 activation and spermatogenic cells are actively eliminated.Results: To elucidate a mechanism of such diverse HSF1 activity we carried out genome-wide transcriptional analysis in control and heat-shocked cells, either spermatocytes or hepatocytes. Additionally, to identify direct molecular targets of active HSF1 we used chromatin immunoprecipitation assay (ChIP) combined with promoter microarrays (ChIP on chip). Genes that are differently regulated after HSF1 binding during hyperthermia in both types of cells have been identified. Despite HSF1 binding to promoter sequences in both types of cells, strong up-regulation ofHspsand other genes typically activated by the heat shock was observed only in hepatocytes. In spermatocytes HSF1 binding correlates with transcriptional repression on a large scale. HSF1-bound and negatively regulated genes encode mainly for proteins required for cell division, involved in RNA processing and piRNA biogenesis.Conclusions: Observed suppression of the transcription could lead to genomic instability caused by meiotic recombination disturbances, which in turn might induce apoptosis of spermatogenic cells. We propose that HSF1-dependent induction of cell death is caused by the simultaneous repression of many genes required for spermatogenesis, which guarantees the elimination of cells damaged during heat shock. Such activity of HSF1 prevents transmission of damaged genetic material to the next generation.